SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: Biomaven who wrote (4893)11/7/2001 12:38:17 PM
From: Harold Engstrom  Read Replies (1) | Respond to of 52153
 
Peter,

What do you think about Biogen now? I am no fan of their ability to exclude compounds early in the clinic, and think their ability to close deals leaves much to be desired. OTOH, they have money, are making money, should have another product in Amevive soon, and have the relationship with Elan WRT Antegren. In a low-interest-rate environment they look more attractive to me. What do you think?

H